Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease

NCT07417670 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Memantine
DRUG: Memantine Oral Tablet

Sponsor

Carnot Laboratories